DarioHealth Corp. (DRIO)

$1.01 12.23% $0.11 Healthcare

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

$30.33M

Mr. Erez Raphael

200.00

New York, NY

Mar 08, 2013

-0.86

$-1.17

1.37

2.26

-28.11%

-6.47

-0.24

0.51

1.37

1.96

-4.41%

-7.91%

Similar stocks (6)

Biodesix, Inc.

BDSX

$1.80 3.45%
Uptrend

Sera Prognostics, Inc.

SERA

$8.05 2.81%
Neutral

FONAR Corporation

FONR

$17.51 0.63%
Downtrend

Exagen Inc.

XGN

$2.81 -1.06%
Uptrend

Neuronetics, Inc.

STIM

$0.93 -1.68%
Downtrend

Psychemedics Corporation

PMD

$2.33 0.00%
Downtrend

ETF Exposure (3)

iShares Micro-Cap ETF

IWC

0.00555%

$126.48 2.14%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$136.02 0.03%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$183.14 2.12%
Uptrend